Rand Report Finds Modest Effect for SB 1160, Calls for Database of UR Decisions

Rand Corp. on Monday reported statistically significant increases in some guideline-concordant care that was exempted from prospective utilization review in the first 30 days of an injury, but the generally modest effects indicate that approval rates for early treatment requests in California were already above 90%. In addition to recommending that the Legislature consider expanding the types of treatments that are exempt from prospective review beyond those included in SB 1160, researchers also recommended that the Department of Industrial Relations establish standardized data collection req...